Pharmaceutical Technology: Controlled Drug Release, Volume 2
Pharmaceutical Technology: Controlled Drug Release, Volume 2
Pharmaceutical Technology: Controlled Drug Release, Volume 2
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
96 CH. 8] TOPICAL RELEASE AND PERMEATION STUDIES<br />
Table 5—<strong>Drug</strong> release from Methocel® matrix formulation containing varied concentrations of propranolol<br />
hydrochloride<br />
Average of three determinations.<br />
Fig. 2—Effect of drug loading on the release profile of propranolol hydrochloride from Methocel ® matrix: , 3.0%;<br />
, 2.0%; □, 1.0%; ○, 0.5%.<br />
DMSO in an effort to enhance drug release through the hairless mouse skin. When the diffusion<br />
membrane itself was soaked with DMSO for 1 h prior to its use, the drug release-permeation was<br />
increased by 40% (Table 6 and Fig. 3). The release patterns of the drug were linear from the<br />
samples containing in some way small amounts of DMSO. The sample without DMSO provided<br />
linear release only up to the first 12 h period of the study. This could be attributed to the<br />
complicated processes involved in the passive diffusion of the drug through the skin. The linear<br />
release suggest that the drug release was zero order.<br />
Using these data, some of the related parameters, i.e. rate constant (K), correlation coefficient<br />
(r) and the values for the Y intercepts, were calculated (Table 7). Comparing these data